Review Article

Role of Janus Kinase (JAK) Inhibitor in Autoimmune Ocular Inflammation: A Systematic Review

Table 3

Previous therapy history of conventional DMARDs.

PatientGenderAgeOcular inflammationMTXCTXCsAMMFLEFAZA

1Female59Keratitis+NANANANANA
2Female45Anterior and intermediate uveitis+NANA+++
3Female40Scleritis++NA+NA+
4Female22Anterior uveitis+NA++NANA
5Female45ScleritisNANANANANANA
6Female43PanuveitisNANANANA+NA
7Female18Panuveitis+NANANANANA
8Female37Anterior uveitis+NANANANA+
9Male21Panuveitis+NA+NANANA
10Male65ScleritisNANANA+NANA
11Male43Conjunctivitis++NA+NANA

Notes: MTX: methotrexate; CTX: cyclophosphamide; CsA: cyclosporine A; MMF: mycophenolate mofetil; LEF: leflunomide; AZA: azathioprine; NA: not available.